| Dr Stephen P Meese, DO | |
|
107 Metker Trl, Suite A, Stanford, KY 40484-1049 | |
| (606) 365-8338 | |
| (606) 365-8142 |
| Full Name | Dr Stephen P Meese |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 28 Years |
| Location | 107 Metker Trl, Stanford, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619949278 | NPI | - | NPPES |
| 64076169 | Medicaid | KY | |
| 2274177 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 34.006666 (Ohio) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 02536 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Buc Newport Llc | 0446574339 | 3 |
| Buc Independence Llc | 3779884747 | 4 |
| Bluegrass Urgent Care Llc | 9830350685 | 4 |
News Archive
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced today that its Chairman & CEO, Dr. Daniel Chain, was granted a patent by the European Patent and Trademark Office related to the use of insulin sensitizers for the prevention and treatment of memory loss and dementia. Insulin sensitizer drugs include Rosiglitazone and Pioglitazone, which have been approved for the treatment of type II diabetes mellitus.
A new study has revealed how the gut's protective mechanisms ramp up significantly with food intake, and at times of the day when mealtimes are anticipated based on regular eating habits.
Scientists in Britain have found that vitamin D supplements may reduce the risk of developing type 1 diabetes.
Mayo Clinic researchers, reporting results of the SMART study, have shown that abnormal results on a stress electrocardiogram are an independent predictor of cardiovascular events such as heart attack, heart failure, hospitalization for chest pain, and death in perimenopausal or menopausal women.
Cole-Parmer Ltd, a leading UK manufacturer of analytical laboratory instruments, announced today that Stuart equipment is being used by Guy's and St Thomas' NHS Foundation Trust, located in London, to improve epidural anaesthesia.
› Verified 6 days ago
| Entity Name | Spring View Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033459854 PECOS PAC ID: 3476557000 Enrollment ID: O20060913000014 |
News Archive
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced today that its Chairman & CEO, Dr. Daniel Chain, was granted a patent by the European Patent and Trademark Office related to the use of insulin sensitizers for the prevention and treatment of memory loss and dementia. Insulin sensitizer drugs include Rosiglitazone and Pioglitazone, which have been approved for the treatment of type II diabetes mellitus.
A new study has revealed how the gut's protective mechanisms ramp up significantly with food intake, and at times of the day when mealtimes are anticipated based on regular eating habits.
Scientists in Britain have found that vitamin D supplements may reduce the risk of developing type 1 diabetes.
Mayo Clinic researchers, reporting results of the SMART study, have shown that abnormal results on a stress electrocardiogram are an independent predictor of cardiovascular events such as heart attack, heart failure, hospitalization for chest pain, and death in perimenopausal or menopausal women.
Cole-Parmer Ltd, a leading UK manufacturer of analytical laboratory instruments, announced today that Stuart equipment is being used by Guy's and St Thomas' NHS Foundation Trust, located in London, to improve epidural anaesthesia.
› Verified 6 days ago
| Entity Name | Bluegrass Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104106954 PECOS PAC ID: 9830350685 Enrollment ID: O20120423000216 |
News Archive
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced today that its Chairman & CEO, Dr. Daniel Chain, was granted a patent by the European Patent and Trademark Office related to the use of insulin sensitizers for the prevention and treatment of memory loss and dementia. Insulin sensitizer drugs include Rosiglitazone and Pioglitazone, which have been approved for the treatment of type II diabetes mellitus.
A new study has revealed how the gut's protective mechanisms ramp up significantly with food intake, and at times of the day when mealtimes are anticipated based on regular eating habits.
Scientists in Britain have found that vitamin D supplements may reduce the risk of developing type 1 diabetes.
Mayo Clinic researchers, reporting results of the SMART study, have shown that abnormal results on a stress electrocardiogram are an independent predictor of cardiovascular events such as heart attack, heart failure, hospitalization for chest pain, and death in perimenopausal or menopausal women.
Cole-Parmer Ltd, a leading UK manufacturer of analytical laboratory instruments, announced today that Stuart equipment is being used by Guy's and St Thomas' NHS Foundation Trust, located in London, to improve epidural anaesthesia.
› Verified 6 days ago
| Entity Name | Buc Crescent Springs Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750635926 PECOS PAC ID: 5890934087 Enrollment ID: O20130619000427 |
News Archive
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced today that its Chairman & CEO, Dr. Daniel Chain, was granted a patent by the European Patent and Trademark Office related to the use of insulin sensitizers for the prevention and treatment of memory loss and dementia. Insulin sensitizer drugs include Rosiglitazone and Pioglitazone, which have been approved for the treatment of type II diabetes mellitus.
A new study has revealed how the gut's protective mechanisms ramp up significantly with food intake, and at times of the day when mealtimes are anticipated based on regular eating habits.
Scientists in Britain have found that vitamin D supplements may reduce the risk of developing type 1 diabetes.
Mayo Clinic researchers, reporting results of the SMART study, have shown that abnormal results on a stress electrocardiogram are an independent predictor of cardiovascular events such as heart attack, heart failure, hospitalization for chest pain, and death in perimenopausal or menopausal women.
Cole-Parmer Ltd, a leading UK manufacturer of analytical laboratory instruments, announced today that Stuart equipment is being used by Guy's and St Thomas' NHS Foundation Trust, located in London, to improve epidural anaesthesia.
› Verified 6 days ago
| Entity Name | Buc Newport Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679982250 PECOS PAC ID: 0446574339 Enrollment ID: O20150126000328 |
News Archive
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced today that its Chairman & CEO, Dr. Daniel Chain, was granted a patent by the European Patent and Trademark Office related to the use of insulin sensitizers for the prevention and treatment of memory loss and dementia. Insulin sensitizer drugs include Rosiglitazone and Pioglitazone, which have been approved for the treatment of type II diabetes mellitus.
A new study has revealed how the gut's protective mechanisms ramp up significantly with food intake, and at times of the day when mealtimes are anticipated based on regular eating habits.
Scientists in Britain have found that vitamin D supplements may reduce the risk of developing type 1 diabetes.
Mayo Clinic researchers, reporting results of the SMART study, have shown that abnormal results on a stress electrocardiogram are an independent predictor of cardiovascular events such as heart attack, heart failure, hospitalization for chest pain, and death in perimenopausal or menopausal women.
Cole-Parmer Ltd, a leading UK manufacturer of analytical laboratory instruments, announced today that Stuart equipment is being used by Guy's and St Thomas' NHS Foundation Trust, located in London, to improve epidural anaesthesia.
› Verified 6 days ago
| Entity Name | Buc Independence Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417330150 PECOS PAC ID: 3779884747 Enrollment ID: O20151216000859 |
News Archive
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced today that its Chairman & CEO, Dr. Daniel Chain, was granted a patent by the European Patent and Trademark Office related to the use of insulin sensitizers for the prevention and treatment of memory loss and dementia. Insulin sensitizer drugs include Rosiglitazone and Pioglitazone, which have been approved for the treatment of type II diabetes mellitus.
A new study has revealed how the gut's protective mechanisms ramp up significantly with food intake, and at times of the day when mealtimes are anticipated based on regular eating habits.
Scientists in Britain have found that vitamin D supplements may reduce the risk of developing type 1 diabetes.
Mayo Clinic researchers, reporting results of the SMART study, have shown that abnormal results on a stress electrocardiogram are an independent predictor of cardiovascular events such as heart attack, heart failure, hospitalization for chest pain, and death in perimenopausal or menopausal women.
Cole-Parmer Ltd, a leading UK manufacturer of analytical laboratory instruments, announced today that Stuart equipment is being used by Guy's and St Thomas' NHS Foundation Trust, located in London, to improve epidural anaesthesia.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen P Meese, DO 107 Metker Trl, Suite A, Stanford, KY 40484-1049 Ph: (606) 365-8338 | Dr Stephen P Meese, DO 107 Metker Trl, Suite A, Stanford, KY 40484-1049 Ph: (606) 365-8338 |
News Archive
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced today that its Chairman & CEO, Dr. Daniel Chain, was granted a patent by the European Patent and Trademark Office related to the use of insulin sensitizers for the prevention and treatment of memory loss and dementia. Insulin sensitizer drugs include Rosiglitazone and Pioglitazone, which have been approved for the treatment of type II diabetes mellitus.
A new study has revealed how the gut's protective mechanisms ramp up significantly with food intake, and at times of the day when mealtimes are anticipated based on regular eating habits.
Scientists in Britain have found that vitamin D supplements may reduce the risk of developing type 1 diabetes.
Mayo Clinic researchers, reporting results of the SMART study, have shown that abnormal results on a stress electrocardiogram are an independent predictor of cardiovascular events such as heart attack, heart failure, hospitalization for chest pain, and death in perimenopausal or menopausal women.
Cole-Parmer Ltd, a leading UK manufacturer of analytical laboratory instruments, announced today that Stuart equipment is being used by Guy's and St Thomas' NHS Foundation Trust, located in London, to improve epidural anaesthesia.
› Verified 6 days ago